Ace Vision Group
Ace Vision Group, Inc. (AVG) is an emerging ophthalmic laser device company dedicated to bringing touchless eye laser therapy to patients suffering from age-related vision loss. The company is pioneering a new rejuvenation therapy for the aging eye, focusing on innovative therapeutics and minimally invasive procedures such as Laser Scleral Microporation (LSM). Their mission is to develop solutions that address the biomechanical dysfunction of the eye associated with presbyopia and other age-related ocular conditions, aiming to improve patients' quality of life through advanced, non-invasive treatments.
Industries
Nr. of Employees
small (1-50)
Ace Vision Group
Products
Ophthalmic laser system for touchless microporation
A laser platform engineered to deliver arrays of micropores to the sclera in a touchless manner to alter scleral biomechanics for presbyopia treatment; currently in clinical evaluation.
AI-driven virtual eye simulation platform
Software platform implementing a digital twin of the eye to model aging, lens and biomechanical changes, and to assist in treatment planning and outcome prediction.
Ophthalmic laser system for touchless microporation
A laser platform engineered to deliver arrays of micropores to the sclera in a touchless manner to alter scleral biomechanics for presbyopia treatment; currently in clinical evaluation.
AI-driven virtual eye simulation platform
Software platform implementing a digital twin of the eye to model aging, lens and biomechanical changes, and to assist in treatment planning and outcome prediction.
Services
Clinical study enrollment and coordination
Support for recruiting and coordinating multi‑site clinical research outside the United States for investigational ophthalmic therapies.
Provider training and procedural education
Training and educational programs for eye care providers on performing touchless scleral microporation procedures and associated clinical workflows.
Digital simulation and treatment planning
AI-enabled virtual eye simulation for modeling aging and personalizing presbyopia treatment strategies.
Clinical study enrollment and coordination
Support for recruiting and coordinating multi‑site clinical research outside the United States for investigational ophthalmic therapies.
Provider training and procedural education
Training and educational programs for eye care providers on performing touchless scleral microporation procedures and associated clinical workflows.
Digital simulation and treatment planning
AI-enabled virtual eye simulation for modeling aging and personalizing presbyopia treatment strategies.
Expertise Areas
- Clinical trial management for ophthalmic devices
- Ophthalmic laser device engineering
- Presbyopia therapeutics and scleral interventions
- Ocular biomechanics and kinematic modeling
Key Technologies
- Laser-based scleral microporation
- Ophthalmic laser systems
- AI-driven digital twin
- Virtual reality simulation